nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—ovarian follicle—ovarian cancer	0.146	0.379	CbGeAlD
Tranexamic Acid—PLG—vein—ovarian cancer	0.104	0.27	CbGeAlD
Tranexamic Acid—PLG—embryo—ovarian cancer	0.0197	0.0512	CbGeAlD
Tranexamic Acid—PLG—Folate Metabolism—FOLR1—ovarian cancer	0.0178	0.0922	CbGpPWpGaD
Tranexamic Acid—PLG—epithelium—ovarian cancer	0.0161	0.0418	CbGeAlD
Tranexamic Acid—PLG—endometrium—ovarian cancer	0.0144	0.0375	CbGeAlD
Tranexamic Acid—PLG—gonad—ovarian cancer	0.0134	0.0348	CbGeAlD
Tranexamic Acid—PLG—uterus—ovarian cancer	0.0133	0.0345	CbGeAlD
Tranexamic Acid—PLG—female reproductive system—ovarian cancer	0.0119	0.031	CbGeAlD
Tranexamic Acid—PLG—female gonad—ovarian cancer	0.0109	0.0282	CbGeAlD
Tranexamic Acid—PLG—testis—ovarian cancer	0.00964	0.025	CbGeAlD
Tranexamic Acid—PLG—Regulation of IGF Activity by IGFBP—MMP2—ovarian cancer	0.00535	0.0277	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—XIAP—ovarian cancer	0.00518	0.0268	CbGpPWpGaD
Tranexamic Acid—SLC15A2—uterine cervix—ovarian cancer	0.0051	0.0132	CbGeAlD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—IKBKG—ovarian cancer	0.00493	0.0255	CbGpPWpGaD
Tranexamic Acid—SLC15A2—endometrium—ovarian cancer	0.00461	0.012	CbGeAlD
Tranexamic Acid—PLG—Orphan transporters—TUBB3—ovarian cancer	0.00458	0.0237	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD1—ovarian cancer	0.00446	0.0231	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—SPARC—ovarian cancer	0.00428	0.0222	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SPARC—ovarian cancer	0.00408	0.0211	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD2—ovarian cancer	0.00401	0.0208	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP2—ovarian cancer	0.00382	0.0198	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP2—ovarian cancer	0.00382	0.0198	CbGpPWpGaD
Tranexamic Acid—SLC15A2—female reproductive system—ovarian cancer	0.00382	0.00993	CbGeAlD
Tranexamic Acid—PLG—Folate Metabolism—SOD1—ovarian cancer	0.00363	0.0188	CbGpPWpGaD
Tranexamic Acid—SLC15A2—female gonad—ovarian cancer	0.00347	0.00903	CbGeAlD
Tranexamic Acid—SLC15A2—vagina—ovarian cancer	0.00345	0.00898	CbGeAlD
Tranexamic Acid—PLG—Folate Metabolism—SOD2—ovarian cancer	0.00326	0.0169	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—ovarian cancer	0.00318	0.0165	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—SOD1—ovarian cancer	0.00311	0.0161	CbGpPWpGaD
Tranexamic Acid—SLC15A2—testis—ovarian cancer	0.00308	0.00801	CbGeAlD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SOD1—ovarian cancer	0.00296	0.0153	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD1—ovarian cancer	0.00288	0.0149	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP9—ovarian cancer	0.00287	0.0149	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—MMP9—ovarian cancer	0.00287	0.0149	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP9—ovarian cancer	0.00287	0.0149	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MMP2—ovarian cancer	0.00267	0.0138	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD2—ovarian cancer	0.00259	0.0134	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGA8—ovarian cancer	0.00255	0.0132	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—ovarian cancer	0.00231	0.012	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EREG—ovarian cancer	0.00227	0.0118	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MUC16—ovarian cancer	0.00224	0.0116	CbGpPWpGaD
Tranexamic Acid—SLC15A2—lymph node—ovarian cancer	0.00223	0.00581	CbGeAlD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.0019	0.00984	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—ovarian cancer	0.00187	0.00971	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—ovarian cancer	0.00187	0.00967	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RAD51C—ovarian cancer	0.00183	0.0095	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—IL6—ovarian cancer	0.00178	0.00924	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CDH1—ovarian cancer	0.00175	0.00907	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK3—ovarian cancer	0.00171	0.00884	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL2—ovarian cancer	0.0017	0.00881	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP2—ovarian cancer	0.00168	0.00873	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—SPARC—ovarian cancer	0.00165	0.00853	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—CASP3—ovarian cancer	0.00164	0.00851	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK1—ovarian cancer	0.00162	0.00841	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00147	0.00764	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—INHA—ovarian cancer	0.00144	0.00747	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00141	0.00733	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—ovarian cancer	0.00141	0.0073	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.00138	0.00715	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CASP3—ovarian cancer	0.00134	0.00694	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—ovarian cancer	0.00127	0.00656	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—ovarian cancer	0.00124	0.00642	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—ovarian cancer	0.00123	0.00636	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Topotecan—ovarian cancer	0.00121	0.00287	CcSEcCtD
Tranexamic Acid—Dyspepsia—Chlorambucil—ovarian cancer	0.0012	0.00284	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Topotecan—ovarian cancer	0.00119	0.00281	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Melphalan—ovarian cancer	0.00119	0.00281	CcSEcCtD
Tranexamic Acid—Migraine—Docetaxel—ovarian cancer	0.00118	0.0028	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	0.00118	0.00611	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00118	0.00279	CcSEcCtD
Tranexamic Acid—Cardiovascular disorder—Doxorubicin—ovarian cancer	0.00118	0.00279	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00118	0.00278	CcSEcCtD
Tranexamic Acid—Anaemia—Vinorelbine—ovarian cancer	0.00117	0.00278	CcSEcCtD
Tranexamic Acid—Fatigue—Chlorambucil—ovarian cancer	0.00117	0.00278	CcSEcCtD
Tranexamic Acid—Atrioventricular block—Epirubicin—ovarian cancer	0.00115	0.00273	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—ovarian cancer	0.00115	0.00596	CbGpPWpGaD
Tranexamic Acid—Malaise—Vinorelbine—ovarian cancer	0.00115	0.00271	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Epirubicin—ovarian cancer	0.00113	0.00268	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Chlorambucil—ovarian cancer	0.00112	0.00266	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00112	0.00579	CbGpPWpGaD
Tranexamic Acid—Ventricular tachycardia—Epirubicin—ovarian cancer	0.00112	0.00265	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Epirubicin—ovarian cancer	0.00112	0.00265	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6ST—ovarian cancer	0.00112	0.00579	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00111	0.00264	CcSEcCtD
Tranexamic Acid—Hypotension—Melphalan—ovarian cancer	0.00111	0.00262	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.0011	0.00261	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—TP53—ovarian cancer	0.00109	0.00566	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—ovarian cancer	0.00109	0.00564	CbGpPWpGaD
Tranexamic Acid—Cramp muscle—Docetaxel—ovarian cancer	0.00108	0.00256	CcSEcCtD
Tranexamic Acid—Myalgia—Vinorelbine—ovarian cancer	0.00108	0.00256	CcSEcCtD
Tranexamic Acid—Arthralgia—Vinorelbine—ovarian cancer	0.00108	0.00256	CcSEcCtD
Tranexamic Acid—Chest pain—Vinorelbine—ovarian cancer	0.00108	0.00256	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00108	0.00256	CcSEcCtD
Tranexamic Acid—Dyspnoea—Topotecan—ovarian cancer	0.00108	0.00256	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00108	0.00255	CcSEcCtD
Tranexamic Acid—Abdominal pain—Chlorambucil—ovarian cancer	0.00108	0.00255	CcSEcCtD
Tranexamic Acid—Renal failure—Paclitaxel—ovarian cancer	0.00107	0.00254	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Paclitaxel—ovarian cancer	0.00107	0.00254	CcSEcCtD
Tranexamic Acid—Discomfort—Vinorelbine—ovarian cancer	0.00107	0.00253	CcSEcCtD
Tranexamic Acid—Dyspepsia—Topotecan—ovarian cancer	0.00107	0.00253	CcSEcCtD
Tranexamic Acid—Atrioventricular block—Doxorubicin—ovarian cancer	0.00107	0.00252	CcSEcCtD
Tranexamic Acid—Dyspnoea—Melphalan—ovarian cancer	0.00106	0.0025	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HSD17B6—ovarian cancer	0.00105	0.00546	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—ovarian cancer	0.00105	0.00546	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal pain—Doxorubicin—ovarian cancer	0.00105	0.00248	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00105	0.00248	CcSEcCtD
Tranexamic Acid—Fatigue—Topotecan—ovarian cancer	0.00104	0.00247	CcSEcCtD
Tranexamic Acid—Dyspepsia—Melphalan—ovarian cancer	0.00104	0.00247	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00104	0.00245	CcSEcCtD
Tranexamic Acid—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.00103	0.00245	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Doxorubicin—ovarian cancer	0.00103	0.00245	CcSEcCtD
Tranexamic Acid—Sinusitis—Paclitaxel—ovarian cancer	0.00103	0.00243	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00102	0.00243	CcSEcCtD
Tranexamic Acid—Fatigue—Melphalan—ovarian cancer	0.00102	0.00242	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Vinorelbine—ovarian cancer	0.00102	0.00241	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—TUBB3—ovarian cancer	0.00102	0.00526	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Docetaxel—ovarian cancer	0.00101	0.0024	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Chlorambucil—ovarian cancer	0.001	0.00237	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IL6—ovarian cancer	0.000999	0.00518	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Topotecan—ovarian cancer	0.000998	0.00236	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Epirubicin—ovarian cancer	0.000994	0.00235	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Topotecan—ovarian cancer	0.000991	0.00235	CcSEcCtD
Tranexamic Acid—Haemoglobin—Paclitaxel—ovarian cancer	0.000986	0.00234	CcSEcCtD
Tranexamic Acid—Haemorrhage—Paclitaxel—ovarian cancer	0.000981	0.00232	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—SPARC—ovarian cancer	0.000978	0.00507	CbGpPWpGaD
Tranexamic Acid—Asthenia—Chlorambucil—ovarian cancer	0.000977	0.00231	CcSEcCtD
Tranexamic Acid—Hypotension—Vinorelbine—ovarian cancer	0.000969	0.00229	CcSEcCtD
Tranexamic Acid—Abdominal pain—Topotecan—ovarian cancer	0.000958	0.00227	CcSEcCtD
Tranexamic Acid—Visual impairment—Paclitaxel—ovarian cancer	0.000946	0.00224	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000944	0.00224	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CD—ovarian cancer	0.000943	0.00489	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Chlorambucil—ovarian cancer	0.000931	0.0022	CcSEcCtD
Tranexamic Acid—Dyspnoea—Vinorelbine—ovarian cancer	0.000924	0.00219	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Doxorubicin—ovarian cancer	0.00092	0.00218	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000918	0.00476	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Paclitaxel—ovarian cancer	0.000917	0.00217	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000913	0.00216	CcSEcCtD
Tranexamic Acid—Renal failure—Docetaxel—ovarian cancer	0.000911	0.00216	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Paclitaxel—ovarian cancer	0.000911	0.00216	CcSEcCtD
Tranexamic Acid—Flushing—Paclitaxel—ovarian cancer	0.000911	0.00216	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Docetaxel—ovarian cancer	0.000908	0.00215	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—DLC1—ovarian cancer	0.000896	0.00464	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000895	0.00212	CcSEcCtD
Tranexamic Acid—Fatigue—Vinorelbine—ovarian cancer	0.000894	0.00212	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Topotecan—ovarian cancer	0.000893	0.00211	CcSEcCtD
Tranexamic Acid—Angiopathy—Paclitaxel—ovarian cancer	0.00089	0.00211	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—ovarian cancer	0.000889	0.00461	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Paclitaxel—ovarian cancer	0.000886	0.0021	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000884	0.00209	CcSEcCtD
Tranexamic Acid—Arrhythmia—Paclitaxel—ovarian cancer	0.000877	0.00208	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Melphalan—ovarian cancer	0.000874	0.00207	CcSEcCtD
Tranexamic Acid—Asthenia—Topotecan—ovarian cancer	0.000869	0.00206	CcSEcCtD
Tranexamic Acid—Vomiting—Chlorambucil—ovarian cancer	0.000865	0.00205	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ATF3—ovarian cancer	0.000857	0.00444	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Vinorelbine—ovarian cancer	0.000854	0.00202	CcSEcCtD
Tranexamic Acid—Asthenia—Melphalan—ovarian cancer	0.000851	0.00202	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000848	0.00201	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000842	0.00436	CbGpPWpGaD
Tranexamic Acid—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000838	0.00198	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000837	0.00434	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Docetaxel—ovarian cancer	0.000836	0.00198	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—ovarian cancer	0.000833	0.00432	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Docetaxel—ovarian cancer	0.000832	0.00197	CcSEcCtD
Tranexamic Acid—Diarrhoea—Topotecan—ovarian cancer	0.000829	0.00196	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000828	0.00196	CcSEcCtD
Tranexamic Acid—Back pain—Paclitaxel—ovarian cancer	0.000826	0.00196	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MTOR—ovarian cancer	0.000822	0.00426	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CB—ovarian cancer	0.000822	0.00426	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Paclitaxel—ovarian cancer	0.000821	0.00194	CcSEcCtD
Tranexamic Acid—Abdominal pain—Vinorelbine—ovarian cancer	0.000819	0.00194	CcSEcCtD
Tranexamic Acid—Diarrhoea—Melphalan—ovarian cancer	0.000812	0.00192	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000809	0.00419	CbGpPWpGaD
Tranexamic Acid—Nausea—Chlorambucil—ovarian cancer	0.000808	0.00191	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000807	0.00418	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000807	0.00418	CbGpPWpGaD
Tranexamic Acid—Visual impairment—Docetaxel—ovarian cancer	0.000802	0.0019	CcSEcCtD
Tranexamic Acid—Dizziness—Topotecan—ovarian cancer	0.000801	0.0019	CcSEcCtD
Tranexamic Acid—Migraine—Epirubicin—ovarian cancer	0.000798	0.00189	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—ovarian cancer	0.000794	0.00411	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000793	0.00188	CcSEcCtD
Tranexamic Acid—Anaemia—Paclitaxel—ovarian cancer	0.00079	0.00187	CcSEcCtD
Tranexamic Acid—Eye disorder—Docetaxel—ovarian cancer	0.000777	0.00184	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000775	0.00184	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Docetaxel—ovarian cancer	0.000772	0.00183	CcSEcCtD
Tranexamic Acid—Flushing—Docetaxel—ovarian cancer	0.000772	0.00183	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1B—ovarian cancer	0.000771	0.004	CbGpPWpGaD
Tranexamic Acid—Vomiting—Topotecan—ovarian cancer	0.00077	0.00182	CcSEcCtD
Tranexamic Acid—Malaise—Paclitaxel—ovarian cancer	0.00077	0.00182	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000766	0.00181	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Vinorelbine—ovarian cancer	0.000764	0.00181	CcSEcCtD
Tranexamic Acid—Headache—Topotecan—ovarian cancer	0.000759	0.0018	CcSEcCtD
Tranexamic Acid—Angiopathy—Docetaxel—ovarian cancer	0.000755	0.00179	CcSEcCtD
Tranexamic Acid—Vomiting—Melphalan—ovarian cancer	0.000754	0.00179	CcSEcCtD
Tranexamic Acid—Immune system disorder—Docetaxel—ovarian cancer	0.000751	0.00178	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Paclitaxel—ovarian cancer	0.000751	0.00178	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Docetaxel—ovarian cancer	0.00075	0.00177	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000746	0.00386	CbGpPWpGaD
Tranexamic Acid—Asthenia—Vinorelbine—ovarian cancer	0.000744	0.00176	CcSEcCtD
Tranexamic Acid—Arrhythmia—Docetaxel—ovarian cancer	0.000743	0.00176	CcSEcCtD
Tranexamic Acid—Convulsion—Paclitaxel—ovarian cancer	0.00074	0.00175	CcSEcCtD
Tranexamic Acid—Migraine—Doxorubicin—ovarian cancer	0.000739	0.00175	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—ovarian cancer	0.000733	0.0038	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BCL9—ovarian cancer	0.000731	0.00379	CbGpPWpGaD
Tranexamic Acid—Arthralgia—Paclitaxel—ovarian cancer	0.000727	0.00172	CcSEcCtD
Tranexamic Acid—Chest pain—Paclitaxel—ovarian cancer	0.000727	0.00172	CcSEcCtD
Tranexamic Acid—Myalgia—Paclitaxel—ovarian cancer	0.000727	0.00172	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00072	0.00373	CbGpPWpGaD
Tranexamic Acid—Nausea—Topotecan—ovarian cancer	0.00072	0.0017	CcSEcCtD
Tranexamic Acid—Discomfort—Paclitaxel—ovarian cancer	0.000719	0.0017	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—SOD1—ovarian cancer	0.000711	0.00368	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—ovarian cancer	0.00071	0.00368	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Vinorelbine—ovarian cancer	0.000709	0.00168	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PPP2R1A—ovarian cancer	0.000707	0.00367	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP2—ovarian cancer	0.000706	0.00366	CbGpPWpGaD
Tranexamic Acid—Nausea—Melphalan—ovarian cancer	0.000705	0.00167	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000704	0.00365	CbGpPWpGaD
Tranexamic Acid—Back pain—Docetaxel—ovarian cancer	0.0007	0.00166	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000697	0.00165	CcSEcCtD
Tranexamic Acid—Muscle spasms—Docetaxel—ovarian cancer	0.000696	0.00165	CcSEcCtD
Tranexamic Acid—Dizziness—Vinorelbine—ovarian cancer	0.000685	0.00162	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Paclitaxel—ovarian cancer	0.000684	0.00162	CcSEcCtD
Tranexamic Acid—Angina pectoris—Epirubicin—ovarian cancer	0.000683	0.00162	CcSEcCtD
Tranexamic Acid—Anaemia—Docetaxel—ovarian cancer	0.000669	0.00158	CcSEcCtD
Tranexamic Acid—Vomiting—Vinorelbine—ovarian cancer	0.000659	0.00156	CcSEcCtD
Tranexamic Acid—Hypotension—Paclitaxel—ovarian cancer	0.000651	0.00154	CcSEcCtD
Tranexamic Acid—Headache—Vinorelbine—ovarian cancer	0.000649	0.00154	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000646	0.00335	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000638	0.00331	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Docetaxel—ovarian cancer	0.000636	0.00151	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—ovarian cancer	0.000635	0.00329	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000635	0.0015	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—NRAS—ovarian cancer	0.000634	0.00328	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Doxorubicin—ovarian cancer	0.000632	0.0015	CcSEcCtD
Tranexamic Acid—Convulsion—Docetaxel—ovarian cancer	0.000627	0.00149	CcSEcCtD
Tranexamic Acid—Dyspnoea—Paclitaxel—ovarian cancer	0.000622	0.00147	CcSEcCtD
Tranexamic Acid—Chest pain—Docetaxel—ovarian cancer	0.000616	0.00146	CcSEcCtD
Tranexamic Acid—Myalgia—Docetaxel—ovarian cancer	0.000616	0.00146	CcSEcCtD
Tranexamic Acid—Arthralgia—Docetaxel—ovarian cancer	0.000616	0.00146	CcSEcCtD
Tranexamic Acid—Nausea—Vinorelbine—ovarian cancer	0.000616	0.00146	CcSEcCtD
Tranexamic Acid—Renal failure—Epirubicin—ovarian cancer	0.000614	0.00145	CcSEcCtD
Tranexamic Acid—Dyspepsia—Paclitaxel—ovarian cancer	0.000614	0.00145	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—ovarian cancer	0.000607	0.00315	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000602	0.00143	CcSEcCtD
Tranexamic Acid—Fatigue—Paclitaxel—ovarian cancer	0.000601	0.00142	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Docetaxel—ovarian cancer	0.000591	0.0014	CcSEcCtD
Tranexamic Acid—Sinusitis—Epirubicin—ovarian cancer	0.000586	0.00139	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Docetaxel—ovarian cancer	0.00058	0.00137	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK1—ovarian cancer	0.000577	0.00299	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—DOK1—ovarian cancer	0.000577	0.00299	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—ovarian cancer	0.000577	0.00299	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000575	0.00136	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00057	0.00135	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000569	0.00295	CbGpPWpGaD
Tranexamic Acid—Renal failure—Doxorubicin—ovarian cancer	0.000568	0.00135	CcSEcCtD
Tranexamic Acid—Haemoglobin—Epirubicin—ovarian cancer	0.000564	0.00134	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CASP3—ovarian cancer	0.000561	0.00291	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Epirubicin—ovarian cancer	0.000561	0.00133	CcSEcCtD
Tranexamic Acid—Hypotension—Docetaxel—ovarian cancer	0.000552	0.00131	CcSEcCtD
Tranexamic Acid—Abdominal pain—Paclitaxel—ovarian cancer	0.000551	0.0013	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000549	0.00285	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—ovarian cancer	0.000545	0.00283	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PPP1CC—ovarian cancer	0.000543	0.00281	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Doxorubicin—ovarian cancer	0.000542	0.00128	CcSEcCtD
Tranexamic Acid—Visual impairment—Epirubicin—ovarian cancer	0.000541	0.00128	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000538	0.00127	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—ovarian cancer	0.000531	0.00275	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Docetaxel—ovarian cancer	0.000527	0.00125	CcSEcCtD
Tranexamic Acid—Eye disorder—Epirubicin—ovarian cancer	0.000524	0.00124	CcSEcCtD
Tranexamic Acid—Haemoglobin—Doxorubicin—ovarian cancer	0.000522	0.00124	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Epirubicin—ovarian cancer	0.000521	0.00123	CcSEcCtD
Tranexamic Acid—Flushing—Epirubicin—ovarian cancer	0.000521	0.00123	CcSEcCtD
Tranexamic Acid—Dyspepsia—Docetaxel—ovarian cancer	0.00052	0.00123	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CAV1—ovarian cancer	0.00052	0.00269	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	0.00052	0.00269	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Doxorubicin—ovarian cancer	0.000519	0.00123	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Paclitaxel—ovarian cancer	0.000514	0.00122	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00051	0.00121	CcSEcCtD
Tranexamic Acid—Fatigue—Docetaxel—ovarian cancer	0.000509	0.00121	CcSEcCtD
Tranexamic Acid—Angiopathy—Epirubicin—ovarian cancer	0.000509	0.00121	CcSEcCtD
Tranexamic Acid—Immune system disorder—Epirubicin—ovarian cancer	0.000507	0.0012	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Epirubicin—ovarian cancer	0.000506	0.0012	CcSEcCtD
Tranexamic Acid—Arrhythmia—Epirubicin—ovarian cancer	0.000501	0.00119	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—ovarian cancer	0.000501	0.0026	CbGpPWpGaD
Tranexamic Acid—Visual impairment—Doxorubicin—ovarian cancer	0.0005	0.00118	CcSEcCtD
Tranexamic Acid—Asthenia—Paclitaxel—ovarian cancer	0.0005	0.00118	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	0.000494	0.00256	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Docetaxel—ovarian cancer	0.000487	0.00115	CcSEcCtD
Tranexamic Acid—Eye disorder—Doxorubicin—ovarian cancer	0.000485	0.00115	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000483	0.00114	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—ovarian cancer	0.000482	0.00114	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—ovarian cancer	0.000482	0.00114	CcSEcCtD
Tranexamic Acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000477	0.00113	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CG—ovarian cancer	0.000473	0.00245	CbGpPWpGaD
Tranexamic Acid—Back pain—Epirubicin—ovarian cancer	0.000472	0.00112	CcSEcCtD
Tranexamic Acid—Angiopathy—Doxorubicin—ovarian cancer	0.000471	0.00112	CcSEcCtD
Tranexamic Acid—Muscle spasms—Epirubicin—ovarian cancer	0.00047	0.00111	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—ovarian cancer	0.000469	0.00111	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000468	0.00111	CcSEcCtD
Tranexamic Acid—Abdominal pain—Docetaxel—ovarian cancer	0.000467	0.00111	CcSEcCtD
Tranexamic Acid—Arrhythmia—Doxorubicin—ovarian cancer	0.000464	0.0011	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—HRAS—ovarian cancer	0.000464	0.0024	CbGpPWpGaD
Tranexamic Acid—Dizziness—Paclitaxel—ovarian cancer	0.000461	0.00109	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Epirubicin—ovarian cancer	0.000453	0.00107	CcSEcCtD
Tranexamic Acid—Anaemia—Epirubicin—ovarian cancer	0.000451	0.00107	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—ovarian cancer	0.000444	0.0023	CbGpPWpGaD
Tranexamic Acid—Vomiting—Paclitaxel—ovarian cancer	0.000443	0.00105	CcSEcCtD
Tranexamic Acid—Malaise—Epirubicin—ovarian cancer	0.00044	0.00104	CcSEcCtD
Tranexamic Acid—Back pain—Doxorubicin—ovarian cancer	0.000437	0.00103	CcSEcCtD
Tranexamic Acid—Headache—Paclitaxel—ovarian cancer	0.000437	0.00103	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Docetaxel—ovarian cancer	0.000435	0.00103	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—ovarian cancer	0.000434	0.00103	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Epirubicin—ovarian cancer	0.000429	0.00102	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	0.000429	0.00222	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000426	0.00221	CbGpPWpGaD
Tranexamic Acid—Asthenia—Docetaxel—ovarian cancer	0.000424	0.001	CcSEcCtD
Tranexamic Acid—Convulsion—Epirubicin—ovarian cancer	0.000423	0.001	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000419	0.000993	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—ovarian cancer	0.000418	0.000989	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CD—ovarian cancer	0.000416	0.00216	CbGpPWpGaD
Tranexamic Acid—Chest pain—Epirubicin—ovarian cancer	0.000416	0.000984	CcSEcCtD
Tranexamic Acid—Arthralgia—Epirubicin—ovarian cancer	0.000416	0.000984	CcSEcCtD
Tranexamic Acid—Myalgia—Epirubicin—ovarian cancer	0.000416	0.000984	CcSEcCtD
Tranexamic Acid—Nausea—Paclitaxel—ovarian cancer	0.000414	0.000981	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HDAC6—ovarian cancer	0.000411	0.00213	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000411	0.00213	CbGpPWpGaD
Tranexamic Acid—Discomfort—Epirubicin—ovarian cancer	0.000411	0.000973	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—ovarian cancer	0.000409	0.00212	CbGpPWpGaD
Tranexamic Acid—Malaise—Doxorubicin—ovarian cancer	0.000407	0.000965	CcSEcCtD
Tranexamic Acid—Diarrhoea—Docetaxel—ovarian cancer	0.000404	0.000957	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Epirubicin—ovarian cancer	0.000399	0.000944	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Doxorubicin—ovarian cancer	0.000397	0.00094	CcSEcCtD
Tranexamic Acid—Convulsion—Doxorubicin—ovarian cancer	0.000392	0.000927	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Epirubicin—ovarian cancer	0.000391	0.000925	CcSEcCtD
Tranexamic Acid—Dizziness—Docetaxel—ovarian cancer	0.000391	0.000925	CcSEcCtD
Tranexamic Acid—Chest pain—Doxorubicin—ovarian cancer	0.000385	0.000911	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—ovarian cancer	0.000385	0.000911	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—ovarian cancer	0.000385	0.000911	CcSEcCtD
Tranexamic Acid—Discomfort—Doxorubicin—ovarian cancer	0.00038	0.0009	CcSEcCtD
Tranexamic Acid—Vomiting—Docetaxel—ovarian cancer	0.000376	0.00089	CcSEcCtD
Tranexamic Acid—Hypotension—Epirubicin—ovarian cancer	0.000372	0.000882	CcSEcCtD
Tranexamic Acid—Headache—Docetaxel—ovarian cancer	0.00037	0.000877	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000369	0.000873	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—YAP1—ovarian cancer	0.000364	0.00189	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000363	0.00086	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CB—ovarian cancer	0.000363	0.00188	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Doxorubicin—ovarian cancer	0.000362	0.000856	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—XIAP—ovarian cancer	0.000357	0.00185	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Epirubicin—ovarian cancer	0.000355	0.000841	CcSEcCtD
Tranexamic Acid—Nausea—Docetaxel—ovarian cancer	0.000351	0.000831	CcSEcCtD
Tranexamic Acid—Dyspepsia—Epirubicin—ovarian cancer	0.000351	0.000831	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	0.00035	0.00182	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SMARCA4—ovarian cancer	0.000348	0.0018	CbGpPWpGaD
Tranexamic Acid—Hypotension—Doxorubicin—ovarian cancer	0.000345	0.000816	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000344	0.000815	CcSEcCtD
Tranexamic Acid—Fatigue—Epirubicin—ovarian cancer	0.000344	0.000814	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—EREG—ovarian cancer	0.000339	0.00176	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000336	0.000796	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IL2—ovarian cancer	0.000333	0.00173	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP2—ovarian cancer	0.00033	0.00171	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Doxorubicin—ovarian cancer	0.000329	0.000779	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Epirubicin—ovarian cancer	0.000328	0.000778	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000326	0.000772	CcSEcCtD
Tranexamic Acid—Dyspepsia—Doxorubicin—ovarian cancer	0.000325	0.000769	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000324	0.00168	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000318	0.000754	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PGR—ovarian cancer	0.000318	0.00165	CbGpPWpGaD
Tranexamic Acid—Fatigue—Doxorubicin—ovarian cancer	0.000318	0.000753	CcSEcCtD
Tranexamic Acid—Abdominal pain—Epirubicin—ovarian cancer	0.000315	0.000746	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Doxorubicin—ovarian cancer	0.000304	0.00072	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000302	0.000714	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PARP1—ovarian cancer	0.000296	0.00153	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Epirubicin—ovarian cancer	0.000294	0.000695	CcSEcCtD
Tranexamic Acid—Abdominal pain—Doxorubicin—ovarian cancer	0.000292	0.00069	CcSEcCtD
Tranexamic Acid—Asthenia—Epirubicin—ovarian cancer	0.000286	0.000677	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—VEGFA—ovarian cancer	0.000283	0.00147	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NRAS—ovarian cancer	0.00028	0.00145	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—ovarian cancer	0.000274	0.00142	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Epirubicin—ovarian cancer	0.000273	0.000646	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Doxorubicin—ovarian cancer	0.000272	0.000643	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MAPK3—ovarian cancer	0.000268	0.00139	CbGpPWpGaD
Tranexamic Acid—Asthenia—Doxorubicin—ovarian cancer	0.000265	0.000627	CcSEcCtD
Tranexamic Acid—Dizziness—Epirubicin—ovarian cancer	0.000264	0.000624	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MAPK1—ovarian cancer	0.000255	0.00132	CbGpPWpGaD
Tranexamic Acid—Vomiting—Epirubicin—ovarian cancer	0.000253	0.0006	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—CTNNB1—ovarian cancer	0.000253	0.00131	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Doxorubicin—ovarian cancer	0.000252	0.000597	CcSEcCtD
Tranexamic Acid—Headache—Epirubicin—ovarian cancer	0.00025	0.000591	CcSEcCtD
Tranexamic Acid—Dizziness—Doxorubicin—ovarian cancer	0.000244	0.000577	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—KRAS—ovarian cancer	0.000241	0.00125	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PPP2R1A—ovarian cancer	0.00024	0.00124	CbGpPWpGaD
Tranexamic Acid—Nausea—Epirubicin—ovarian cancer	0.000237	0.000561	CcSEcCtD
Tranexamic Acid—Vomiting—Doxorubicin—ovarian cancer	0.000234	0.000555	CcSEcCtD
Tranexamic Acid—Headache—Doxorubicin—ovarian cancer	0.000231	0.000547	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—ovarian cancer	0.000221	0.00115	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—ovarian cancer	0.000219	0.000519	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TP53—ovarian cancer	0.000214	0.00111	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HRAS—ovarian cancer	0.000205	0.00106	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TERT—ovarian cancer	0.00019	0.000987	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—ovarian cancer	0.000181	0.000936	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CAV1—ovarian cancer	0.000176	0.000913	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ESR1—ovarian cancer	0.00017	0.00088	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6ST—ovarian cancer	0.000167	0.000866	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CG—ovarian cancer	0.00016	0.000832	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APC—ovarian cancer	0.00016	0.000832	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CD—ovarian cancer	0.000141	0.000731	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—ovarian cancer	0.000125	0.000646	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CB—ovarian cancer	0.000123	0.000637	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MTOR—ovarian cancer	0.000123	0.000637	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—ovarian cancer	0.000118	0.000612	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1B—ovarian cancer	0.000115	0.000598	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP3—ovarian cancer	0.000113	0.000586	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—ovarian cancer	0.000113	0.000585	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—ovarian cancer	0.00011	0.000571	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CTNNB1—ovarian cancer	0.000109	0.000565	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—ovarian cancer	0.000107	0.000554	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—ovarian cancer	0.000106	0.000551	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—ovarian cancer	9.6e-05	0.000497	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—ovarian cancer	9.5e-05	0.000493	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NRAS—ovarian cancer	9.48e-05	0.000491	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—ovarian cancer	9.08e-05	0.000471	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—ovarian cancer	8.83e-05	0.000458	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK1—ovarian cancer	8.64e-05	0.000448	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—ovarian cancer	8.64e-05	0.000448	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—ovarian cancer	8.16e-05	0.000423	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—ovarian cancer	7.5e-05	0.000389	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—ovarian cancer	7.25e-05	0.000376	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRAS—ovarian cancer	6.94e-05	0.000359	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—ovarian cancer	6.64e-05	0.000344	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—ovarian cancer	6.12e-05	0.000317	CbGpPWpGaD
